SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Daytrading Canadian stocks in Realtime -- Ignore unavailable to you. Want to Upgrade?


To: Sapper who wrote (3618)2/6/1999 5:59:00 PM
From: John Fairchild  Respond to of 62348
 
For anyone with interest in IMM-V Immune Network. Louis Paquette editor of Emerging Growth Stocks (EGM) Newsletter posts at the Stockhouse IMM forum fairly regularly. He put out an update on IMM the day of the NR (Jan 4).

stockhouse.com

This is what Lou had to say on the forum this afternoon (Sat):
++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
"Impressive volume and chart break-out this week on the IMM chart. Looks like there is some momentum here. I heard from many readers and a couple of money managers who are loading up on the stock. The next month or two should be most interesting."
++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++

IMM hit .34 last summer very early in the study. No reason to think it can't move past that level now that the study is complete and assays are being performed by the National Institute of Health lab.

Hope you guys don't think I am spaming this thing but I do think it is on its way back up to at least last summers trading range. I have bought as much as I can. Lou has stated in the past that this one is heavily owned by those who know the science. I owned Forbes Meditech when it was a buck and change just over a year ago and did not know enough to hang on for the big gains. I hope to make up for that error in judgement with IMM.

IMM #10 in highest volume on friday (it been a long time since they made that list). It was a great daytrader last summer with what I suspect were a lot of unsophisticated buyers (scientists not traders).

John.